Picture of Tomas Matejovsky

Tomas Matĕjovský

Partner
Head of Commercial, Regulatory and Disputes

CMS Cameron McKenna v.o.s.
Palladium, Na Poříčí 1079/3a
110 00 Prague 1
Czech Republic
Languages French, English, Czech

Tomas Matĕjovský is a partner and the Head of the Commercial, Regulatory and Disputes practice at CMS Prague.

He focuses on litigation and arbitration, compliance matters and white collar crime, and on commercial law, including employment, IP and competition. As part of his practice he represents clients in various types of litigations and arbitration proceedings at all levels, such as commercial, unfair competition and damage claim disputes before regional courts, Superior Courts, the Supreme Court, and the Constitutional Court and various arbitration bodies.

Tomas also advises Czech and international companies on sector specific regulatory issues with particular focus on highly regulated industries such as the lifesciences, technology, media and communications sectors. His clients include major multinationals in these sectors.

In addition, he also supports clients on negotiating complex commercial agreements and advises on investments and investment incentives schemes in the CEE region.

more less

"Great knowledge of the legal system and excellent communication skills."

Chambers

Relevant experience

  • The Austrian and Slovak subsidiaries of Siemens in a major cross-border dispute over alleged pre-tender contractual liabilities linked to an important bidding process for railway security equipment.
  • Eastern Sugar in the Czech Republic in a EUR 41m claim against the Czech Republic.
  • Ministry of Agriculture concerning a wrongful allocation of its sugar quota and related significant ECHR claim against the Czech Republic.
  • Ministry of Finance of the Czech Republic in a significant arbitration valued at EUR 78.8m against a shareholder of a major Czech coal producer relating to a possible breach of a privatisation agreement by which the state's share was sold.
  • Global technology company and its insurers in a major multimillion euro damage claims regarding delivery and use of faulty electrical devices that caused a fire in one of the Prague’s main shopping gallery and office space in the centre of town, therefore representing a major health and safety risk.
  • A major telecommunications operator on the first stand-alone competition dispute with a competitor regarding margin squeeze in respect to providing of and access to broadband xDSL internet.
  • Diageo on the Czech regulation of food products and beverages, including labelling and packaging advice and distribution arrangements advice.
  • A leading biopharmaceutical company on all matters, including advising on employment law and lifesciences sector specific regulatory matters.
  • A global software company on several cyber-squatting and domain name matters and disputes as well as on trademark infringement issues, including oppositions against trademark applications.
  • A global IT company on several criminal investigations in relation to alleged bribery and corruption issues.
  • Worldwide medical devices producer on several compliance and anti-corruption investigations and relating matters. 
more less

Education

1999 - International Law and State Administration Course, Ecole National d'Administration, Paris, France

1998 - European Law, History and French Course, Universite de Perpignan, Perpignan, France

1997 - Law Degree, Charles University, Prague

more less

Memberships

Member - Czech Bar Association

more less

Feed

Show only
16/08/2016
Greenfield Investments in CEE
21/04/2017
Significant amendments to Czech Insolvency Act
The new Amendment on the Czech Insolvency Act (the “Amendment”) will enter into force on 1 July 2017. The Amendment introduces a “liquidity gap” test, which will be used when a debtor (entrepreneur) needs to determine whether it is considered insolvent or.
15/12/2015
CMS Global Lifesciences Forum 2015
Shaping the future through innovation and collabor...
28/02/2017
New Amendment to the Pharmaceuticals Act in the Czech Republic
A new amendment to the Pharmaceuticals Act was signed by the Czech President on 14 February 2017 (“Amendment”). Under the Amendment, distributors will be obliged to supply pharmaceuticals within two business days upon receipt of a pharmacy’s request.
12/12/2016
New guideline for state prosecutors on criminal liability of lega...
On 8 September 2016 we published an eAlert regarding the amendment to the Act on Criminal Liability of Legal Entities, which contains a new defence for legal entities. Under the amendment a legal entity will be excluded from criminal liability provided it can.
02/12/2016
New requirements for loan providers in the Czech Republic
Tens of thousands of moneylenders are affected by the new Act on Consumer Credit (the “Act”) which entered into force on 1 December 2016. The Act introduces a stringent licensing procedure with the Czech National Bank (CNB) for non-bank loan providers and loan.
30/11/2016
New Amendment to the Pharmaceuticals Act
On 9 November 2016 the Chamber of Deputies passed a new amendment to Act No. 378/2007 Coll. , on Pharmaceuticals (the “Amendment”). It stipulates that the State Institute for Drug Control (“SUKL”) will collect and analyse data from market authorisation holders,.
20/10/2016
New legislation on electronic identification and authentication
Better late than never – this is an apt description of the adoption of new legislation on electronic identification and authentication in the Czech Republic. Although the Regulation (EU) no. 910/2014 of the European Parliament and of the Council of 23 July.
14/10/2016
New ruling on the compatibility of functions
A new ruling of the Czech Constitutional Court represents a turning point in the compatibility of a performance agreement with an employment agreement. Under previous case law of the Supreme Court, one could not simultaneously be a member of a statutory body.
15/09/2016
Czech Republic to strengthen consumer credit regulation
The new Czech Act on Consumer Loans (the “Act”) was published recently and will enter into force on 1 December 2016. Under the Act, lenders will be subject to a licensing procedure with the Czech National Bank, required to possess a capital stock of at least.
08/09/2016
New amendment to the Act on Criminal Liability of Legal Entities
On 1 June 2016 the President of the Czech Republic signed an amendment to the Act on Criminal Liability of Legal Entities and Proceedings Against Them (the “Amendment”). The Amendment will come into force on 1 December 2016 as the number of crimes which can.
01/09/2016
Czech government amends law on Tax Evasion
On 1 July 2016 a new amendment of the Criminal Procedural Code and Criminal Act (the “Amendment”) came into force. The Amendment introduces criminal liability for the avoidance of taxes, fees and similar mandatory payments (“Tax Evasion”), in cases where the.
26/08/2016
Suspects of corruption in the Czech Republic to escape criminal p...
On 1 July 2016 a new amendment to the Criminal Procedural Code and Criminal Act (the “Amendment”) came into force. A police authority can now decide on the temporary suspension of the criminal prosecution of a suspect if the suspect provided or promised to.